Induction of AKR1C2 by phase II inducers: Identification of a distal consensus antioxidant response element regulated by NRF2

Molecular Pharmacology

Volumn 69, Issue 5, 2006, Pages 1662-1672

  Lou, Huan ^a   Du, Shouying ^a   Ji, Qing ^a   Stolz, Andrew ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b Hoffman Medical Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3ALPHA HYDROXYSTEROID DEHYDROGENASE; BETA NAPHTHOFLAVONE; DNA; ELLAGIC ACID; ENZYME INDUCING AGENT; ETACRYNIC ACID; ISOENZYME; NUCLEAR FACTOR; REACTIVE OXYGEN METABOLITE; TERT BUTYLHYDROQUINONE; TRANSCRIPTION FACTOR NRF2;

ANIMAL CELL; ANTIOXIDANT RESPONSIVE ELEMENT; ARTICLE; BIOACCUMULATION; CELL DAMAGE; CELL NUCLEUS; CELL STRAIN HEPG2; CELL STRAIN HT29; CELLULAR DISTRIBUTION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DETOXIFICATION; DNA DETERMINATION; DNA MICROARRAY; DNA RESPONSIVE ELEMENT; DNA SEQUENCE; ENHANCER REGION; ENZYME INDUCTION; FIBROBLAST; GEL MOBILITY SHIFT ASSAY; GENE CONTROL; GENE IDENTIFICATION; GENE LOCATION; GENETIC TRANSFECTION; HORMONE METABOLISM; HUMAN; HUMAN CELL; KNOCKOUT GENE; MOUSE; MUTATIONAL ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REGULATORY MECHANISM; SEQUENCE HOMOLOGY; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION REGULATION; XENOBIOTIC METABOLISM;

BASE SEQUENCE; CELL LINE, TUMOR; CELL NUCLEUS; CHROMATIN; DNA PRIMERS; ENZYME INDUCTION; HUMANS; HYDROXYSTEROID DEHYDROGENASES; NF-E2-RELATED FACTOR 2; SEQUENCE DELETION;

EID: 33645893202     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.105.019794     Document Type: Article

References (47)

1. Bahar RJ and Stolz A (1999) Bile acid transport. Gastroenterol Clin North Am 28:27-58.
2. Burczynski ME, Lin HK, and Penning TM (1999) Isoform-specific induction of a human aldo-keto reductase by polycyclic aromatic hydrocarbons (PAHs), electrophiles and oxidative stress: implications for the alternative pathway of PAH activation catalyzed by human dihydrodiol dehydrogenase. Cancer Res 59:607-614.
3. Chen CY, Hsu CP, Hsu NY, Shih CS, Lin TY, and Chow KC (2002) Expression of dihydrodiol dehydrogenase in the resected stage I non-small cell lung cancer. Oncol Rep 9:515-519.
4. Chomczynski P and Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
5. Ciaccio PJ, Jaiswal AK, and Tew KD (1994) Regulation of human dihydrodiol dehydrogenase by Michael acceptor xenobiotics. J Biol Chem 269:15558-15562.
6. Ciaccio PJ, Stuart JE, and Tew KD (1993) Overproduction of a 37.5-kDa cytosolic protein structurally related to prostaglandin F synthase in ethacrynic acid-resistant human colon cells. Mol Pharmacol 43:845-853.
7. Ciaccio PJ, Walsh ES, and Tew KD (1996) Promoter analysis of a human dihydrodiol dehydrogenase. Biochem Biophys Res Commun 228:524-529.
8. Deng HB, Adikari M, Parekh HK, and Simpkins H (2004) Ubiquitous induction of resistance to platinum drugs in human ovarian, cervical, germ-cell and lung carcinoma tumor cells overexpressing isoforms 1 and 2 of dihydrodiol dehydrogenase. Cancer Chemother Pharmacol 54:301-307.
9. Deng HB, Parekh HK, Chow KC, and Simpkins H (2002) Increased expression of dihydrodiol dehydrogenase induces resistance to cisplatin in human ovarian carcinoma cells. J Biol Chem 277:15035-15043.
10. Dignam JD, Lebovitz RM, and Roeder RG (1983) Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 11:1475-1489.
11. Dufort I, Soucy P, Labrie F, and Luu-The V (1996) Molecular cloning of human type 3 3a-hydroxysteroid dehydrogenase that differs from 20α-hydroxysteroid dehydrogenase by seven amino acids. Biochem Biophys Res Commun 228:474-479.
12. Ellis EM, Slattery CM, and Hayes JD (2003) Characterization of the rat aflatoxin B1 aldehyde reductase gene, AKR7A1. Structure and chromosomal localization of AKR7A1 as well as identification of antioxidant response elements in the gene promoter. Carcinogenesis 24:727-737.
13. Favreau LV and Pickett CB (1993) Transcriptional regulation of the rat NAD(P)H: quinone reductase gene. Characterization of a DNA-protein interaction at the antioxidant responsive element and induction by 12-O-tetradecanoylphorbol 13-acetate. J Biol Chem 268:19875-19881.
14. Hara A, Taniguchi H, Nakayama T, and Sawada H (1990) Purification and properties of multiple forms of dihydrodiol dehydrogenase from human liver. J Biochem (Tokyo) 108:250-254.
15. Heredia VV and Penning TM (2004) Dissection of the physiological interconversion of 5alpha-DHT and 3alpha-diol by rat 3alpha-HSD via transient kinetics shows that the chemical step is rate-determining: effect of mutating cofactor and substrate-binding pocket residues on catalysis. Biochemistry 43:12028-12037.
16. Hsu NY, Ho HC, Chow KC, Lin TY, Shih CS, Wang LS, and Tsai CM (2001) Overexpression of dihydrodiol dehydrogenase as a prognostic marker of non-small cell lung cancer. Cancer Res 61:2727-2731.
17. Jez JM and Penning TM (2001) The aldo-keto reductase (AKR) superfamily: an update. Chem Biol Interact 130-132:499-525.
18. Ji Q, Aoyama C, Nien YD, Liu PI, Chen PK, Chang L, Stanczyk FZ, and Stolz A (2004) Selective loss of AKR1C1 and AKR1C2 in breast cancer and their potential effect on progesterone signaling. Cancer Res 64:7610-7617.
19. Ji Q, Chang L, VanDenBerg D, Stanczyk FZ, and Stolz A (2003) Selective reduction of AKR1C2 in prostate cancer and its role in DHT metabolism. Prostate 54:275-289.
20. Kazemi-Noureini S, Colonna-Romano S, Ziaee AA, Malboobi MA, Yazdanbod M, Setayeshgar P, and Maresca B (2004) Differential gene expression between squamous cell carcinoma of esophageus and its normal epithelium; altered pattern of mal, akr1c2 and rab11a expression. World J Gastroenterol 10:1716-1721.
21. Khanna M, Qin KN, Wang RW, and Cheng KC (1995) Substrate specificity, gene structure and tissue-specific distribution of multiple human 3α-hydroxysteroid dehydrogenases. J Biol Chem 270:20162-20168.
22. Leung L, Kwong M, Hou S, Lee C, and Chan JY (2003) Deficiency of the Nrf1 and Nrf2 transcription factors results in early embryonic lethality and severe oxidative stress. J Biol Chem 278:48021-48029.
23. Lewis MJ, Wiebe JP, and Heathcote JG (2004) Expression of progesterone metabolizing enzyme genes (AKR1C1, AKR1C2, AKR1C3, SRD5A1, SRD5A2) is altered in human breast carcinoma. BMC Cancer 4:27.
24. Lou H, Hammond L, Sharma V, Sparkes RS, Lusis AJ, and Stolz A (1994) Genomic organization and chromosomal localization of a novel human hepatic dihydrodiol dehydrogenase with high affinity bile acid binding. J Biol Chem 269:8416-8422.
25. McKnight SL, Gavis ER, Kingsbury R, and Axel R (1981) Analysis of transcriptional regulatory signals of the HSV thymidine kinase gene: identification of an upstream control region. Cell 25:385-398.
26. Motohashi H and Yamamoto M (2004) Nrf2-Keap1 defines a physiologically important stress response mechanism. Trends Mol Med 10:549-557.
27. Nguyen T, Yang CS, and Pickett CB (2004) The pathways and molecular mechanisms regulating Nrf2 activation in response to chemical stress. Free Radic Biol Med 37:433-441.
28. Nioi P, McMahon M, Itoh K, Yamamoto M, and Hayes JD (2003) Identification of a novel Nrf2-regulated antioxidant response element (ARE) in the mouse NAD(P)H: quinone oxidoreductase 1 gene: reassessment of the ARE consensus sequence. Biochem J 374:337-348.
29. Nishinaka T and Yabe-Nishimura C (2005) Transcription factor Nrf2 regulates promoter activity of mouse aldose reductase (AKR1B3) gene. J Pharmacol Sci 97:43-51.
30. Nishizawa M, Nakajima T, Yasuda K, Kanzaki H, Sasaguri Y, Watanabe K, and Ito S (2000) Close kinship of human 20alpha-hydroxysteroid dehydrogenase gene with three aldo-keto reductase genes. Genes Cells 5:111-125.
31. Nobel S, Abrahmsen L, and Oppermann U (2001) Metabolic conversion as a prereceptor control mechanism for lipophilic hormones. Eur J Biochem 268:4113-4125.
32. Ozeki T, Takahashi Y, Kume T, Nakayama K, Yokoi T, Nunoya K, Hara A, and Kamataki T (2001) Co-operative regulation of the transcription of human dihydrodiol dehydrogenase (DD)4/aldo-keto reductase (AKR)1C4 gene by hepatocyte nuclear factor (HNF)-4alpha/gamma and HNF-1alpha. Biochem J 355:537-544.
33. Ozeki T, Takahashi Y, Nakayama K, Funayama M, Nagashima K, Kodama T, and Kamataki T (2003) Hepatocyte nuclear factor-4 alpha/gamma and hepatocyte nuclear factor-1 alpha as causal factors of interindividual difference in the expression of human dihydrodiol dehydrogenase 4 mRNA in human livers. Pharmacogenetics 13:49-53.
34. Ozeki T, Takahashi Y, Nakayama K, and Kamataki T (2002) Hepatocyte nuclear factor (HNF)-4 alpha/gamma, HNF-1 alpha and vHNF-1 regulate the cell-specific expression of the human dihydrodiol dehydrogenase (DD)4/AKR1C4 gene. Arch Biochem Biophys 405:185-190.
35. Palackal NT, Lee SH, Harvey RG, Blair IA, and Penning TM (2002) Activation of polycyclic aromatic hydrocarbon trans-dihydrodiol proximate carcinogens by human aldo-keto reductase (AKR1C) enzymes and their functional overexpression in human lung carcinoma (A549) cells. J Biol Chem 277:24799-24808.
36. Pelkonen O and Saarni H (1980) Unusual patterns of benzo[a]pyrene metabolites and DNA-benzo[a]pyrene adducts produced by human placental microsomes in vitro. Chem Biol Interact 30:287-296.
37. Penning TM (1993) Dihydrodiol dehydrogenase and its role in polycyclic aromatic hydrocarbon metabolism. Chem Biol Interact 89:1-34.
38. Penning TM (1997) Molecular endocrinology of hydroxysteroid dehydrogenases. Endocrine Rev 18:281-305.
39. Penning TM, Burczynski ME, Jez JM, Hung CF, Lin HK, Ma H, Moore M, Palackal N, and Ratnam K (2000) Human 3alpha-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones. Biochem J 351:67-77.
40. Prochaska HJ and Talalay P (1988) Regulatory mechanisms of monofunctional and bifunctional anticarcinogenic enzyme inducers in murine liver. Cancer Res 48: 4776-4782.
41. Steckelbroeck S, Jin Y, Gopishetty S, Oyesanmi B, and Penning TM (2004) Human cytosolic 3α-hydroxysteroid dehydrogenases of the aldo-keto reductase superfamily display significant 3β-hydroxysteroid dehydrogenase activity: implications for steroid hormone metabolism and action. J Biol Chem 279:10784-10795.
42. Stolz A, Rahimi-Kiani M, Ameis D, Chan E, and Shively JE (1991) Molecular structure of rat hepatic 3α-hydroxysteroid dehydrogenase. A member of the oxidoreductase gene family. J Biol Chem 266:15253-15257.
43. Stolz A, Sugiyama Y, Kuhlenkamp J, and Kaplowitz N (1984) Identification and purification of a 36 kDa bile acid binder in human hepatic cytosol. FEBS Lett 177:31-35.
44. Takikawa H, Stolz A, Sugiyama Y, Yoshida H, Yamanaka M, and Kaplowitz N (1990) Relationship between the newly identified bile acid binder and bile acid oxidoreductases in human liver. J Biol Chem 265:2132-2136.
45. Thimmulappa RK, Mai KH, Srisuma S, Kensler TW, Yamamoto M, and Biswal S (2002) Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray. Cancer Res 62:5196-5203.
46. Wasserman WW and Fahl WE (1997) Functional antioxidant responsive elements. Proc Natl Acad Sci USA 94:5361-5366.
47. Xanthopoulos KG and Mirkovitch J (1993) Gene regulation in rodent hepatocytes during development, differentiation and disease. Eur J Biochem 216:353-360.